Legence Corp. S-1 Reveals Strong Growth, $3.1B Backlog Amid Secondary Offering

TL;DR

**This secondary offering is a red flag for new investors, as existing holders are cashing out without injecting fresh capital into Legence, despite its impressive $3.1 billion backlog.**

AI Summary

Legence Corp. (LGN) is a leading provider of engineering, installation, and maintenance services for mission-critical building systems, focusing on high-growth sectors like technology, life sciences, healthcare, and education. The company reported a robust revenue compound annual growth rate (CAGR) of approximately 39% from 2021 to 2024, or 16% pro forma for acquisitions. In 2024, over half of its revenues came from high-growth industries, and 67.5% of revenues were derived from retrofits, upgrades, and maintenance for existing buildings. As of September 30, 2025, Legence had a significant backlog and awarded contracts totaling $3.1 billion, marking a 29% increase year-over-year. The company operates through two segments: Engineering & Consulting, which grew at an 83% CAGR (15% pro forma) from 2021-2024 and contributed 28.7% of revenues in 2024, and Installation & Maintenance, which grew at a 30% CAGR (16% pro forma) and contributed 71.3% of revenues in 2024. Approximately 25% of 2024 revenues, or $545 million, were generated from clients utilizing both segments, demonstrating cross-selling success. The S-1 filing indicates a secondary offering of 7,000,000 shares of Class A Common Stock by selling stockholders, with Legence Corp. not receiving any proceeds from this sale. Key risks include reliance on a limited number of large clients and the cyclical nature of construction and renovation projects.

Why It Matters

This S-1 filing is crucial for investors as it details a secondary offering of 7,000,000 Class A Common Stock shares by existing stockholders, meaning Legence Corp. itself will not receive any capital. While the company demonstrates impressive revenue growth (39% CAGR 2021-2024) and a substantial $3.1 billion backlog, the lack of direct capital infusion from this offering means no immediate boost to its balance sheet for expansion or debt reduction. For employees and customers, the continued growth in high-demand sectors like data centers and healthcare suggests stable demand for Legence's specialized MEP services. Competitively, Legence's 'one-stop solution' for engineering, installation, and maintenance, coupled with its client base including over 60% of Nasdaq-100 companies, positions it strongly against fragmented competitors, but the market will scrutinize its ability to sustain this growth without new primary capital.

Risk Assessment

Risk Level: medium — The risk level is medium because while Legence Corp. exhibits strong growth (39% revenue CAGR 2021-2024) and a substantial $3.1 billion backlog, the current S-1 filing is for a secondary offering where the company will not receive any proceeds. This means no new capital for growth or debt reduction, which could limit future expansion. Additionally, the company's reliance on a concentrated client base, with six of its top ten clients engaging both segments, presents a concentration risk.

Analyst Insight

Investors should exercise caution and thoroughly evaluate the implications of a secondary offering where the company receives no proceeds. While Legence's operational performance and market position are strong, consider the potential for dilution and the lack of new capital for corporate initiatives. Monitor future filings for primary offerings or strategic uses of existing capital.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

+39%

Revenue Breakdown

Key Numbers

• $47.50 — Last reported sale price of Class A Common Stock (As of December 8, 2025, on Nasdaq)
• 7,000,000 — Shares of Class A Common Stock offered by selling stockholders (No proceeds to Legence Corp. from this offering)
• 1,050,000 — Additional shares option for underwriters (Granted by selling stockholders for 30 days)
• 39% — Compound annual growth rate of revenues (From 2021 to 2024, indicating rapid expansion)
• 16% — Pro forma compound annual growth rate of revenues (From 2021 to 2024, after giving effect to acquisitions)
• $3.1 billion — Backlog and awarded contracts (As of September 30, 2025, representing a 29% increase year-over-year)
• 67.5% — Revenue from retrofits, upgrades, and maintenance (In 2024, indicating a strong recurring revenue component)
• 28.7% — Engineering & Consulting segment revenue contribution (In 2024, demonstrating segment's share of total revenue)
• 71.3% — Installation & Maintenance segment revenue contribution (In 2024, highlighting its dominant share of total revenue)
• $545 million — Revenue from clients engaging both segments (In 2024, after pro forma effect to acquisitions, showing cross-selling success)

Key Players & Entities

• Legence Corp. (company) — Registrant and issuer of Class A Common Stock
• Jeffrey Sprau (person) — Chief Executive Officer of Legence Corp.
• Goldman Sachs & Co. LLC (company) — Joint Lead Book-Running Manager for the offering
• Jefferies (company) — Joint Lead Book-Running Manager for the offering
• Blackstone Capital Markets (company) — Co-Manager for the offering
• Blackstone Inc. (company) — Sponsor and investment funds associated with Legence
• Nasdaq-100 Index (regulator) — Benchmark for client base, with Legence serving over 60% of companies
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
• Kirkland & Ellis LLP (company) — Legal counsel for the registrant
• Davis Polk & Wardwell LLP (company) — Legal counsel for the underwriters

FAQ

Risk Factors

• Client Concentration [high — market]: The company relies on a limited number of large clients for a significant portion of its revenue. A loss of one or more of these key clients could materially and adversely affect its business, financial condition, and results of operations.
• Cyclical Nature of Construction [medium — market]: Legence Corp.'s business is subject to the cyclical nature of the construction and renovation industries. Downturns in these sectors, driven by economic conditions or other factors, can reduce demand for its services.
• Integration of Acquisitions [medium — operational]: The company has grown through acquisitions, and its ability to successfully integrate these businesses, including realizing anticipated synergies and managing potential disruptions, is critical to its continued growth and profitability.
• Project Execution and Delays [medium — operational]: The successful execution of complex building system projects is crucial. Delays, cost overruns, or failure to meet performance standards on projects could lead to financial losses and damage its reputation.

Industry Context

Legence Corp. operates in the mission-critical building systems sector, serving high-growth industries like technology, life sciences, healthcare, and education. The market is characterized by a significant portion of revenue derived from retrofits, upgrades, and maintenance of existing buildings, suggesting a stable recurring revenue base alongside new construction projects. The industry is subject to construction cycles and client concentration.

Regulatory Implications

While the S-1 filing itself is a regulatory requirement for public offerings, specific regulatory risks mentioned are tied to the construction and building services industry. Compliance with building codes, environmental regulations, and labor laws are ongoing operational considerations.

What Investors Should Do

1. Analyze the sustainability of the 39% reported revenue CAGR, considering the 16% pro forma growth rate to understand the organic vs. acquisition-driven expansion.
2. Evaluate the client concentration risk, particularly the revenue dependency on the largest clients and the potential impact of losing any single major customer.
3. Assess the company's ability to integrate past and future acquisitions effectively, given the pro forma growth figures suggest a strategy reliant on M&A.
4. Monitor the backlog growth and conversion rate to gauge future revenue performance and the company's capacity to execute on awarded contracts.

Key Dates

• 2021-2024: Revenue Growth Period — Demonstrates a historical revenue CAGR of 39% (16% pro forma), indicating rapid expansion.
• 2024: High-Growth Sector Revenue — Over half of revenues were generated from high-growth industries (technology, life sciences, healthcare, education).
• 2024: Retrofit/Maintenance Revenue Share — 67.5% of revenues came from retrofits, upgrades, and maintenance, highlighting a stable revenue base.
• 2025-09-30: Backlog and Awarded Contracts — Totaled $3.1 billion, a 29% year-over-year increase, indicating strong future revenue visibility.
• 2025-12-08: Last Reported Sale Price — $47.50 per share of Class A Common Stock on Nasdaq.
• N/A: Secondary Offering — 7,000,000 shares of Class A Common Stock offered by selling stockholders, with no proceeds to Legence Corp.

Glossary

CAGR

Compound Annual Growth Rate, a measure of the average annual growth rate of an investment over a specified period of time longer than one year. (Used to quantify Legence Corp.'s historical revenue growth, both reported and pro forma for acquisitions.)

Pro Forma

A method of financial reporting that presents financial information as if certain events, such as acquisitions or divestitures, had occurred at an earlier date. (Essential for understanding Legence Corp.'s growth trajectory, particularly the impact of acquisitions on its revenue.)

Backlog

The total value of work that has been contracted but not yet completed or billed. (Indicates future revenue potential and provides insight into the company's demand and project pipeline.)

Secondary Offering

An offering where existing shareholders sell their shares to the public, rather than the company issuing new shares. (Indicates that current investors are seeking liquidity, and Legence Corp. will not receive any capital from this specific sale.)

Year-Over-Year Comparison

This analysis is based on a single S-1 filing, so a direct comparison to a previous filing is not possible. However, the S-1 highlights significant growth, with a reported revenue CAGR of 39% from 2021-2024 (16% pro forma). The backlog has increased by 29% year-over-year as of September 30, 2025, indicating strong forward momentum. Key risks such as client concentration and the cyclical nature of construction remain prominent concerns.

Key Financial Figures

• $0.01 — ares of Class A common stock, par value $0.01 per share ("Class A Common Stock"), to
• $47.50 — Class A Common Stock on the Nasdaq was $47.50 per share. Investing in our Class A C
• $3.1 billion — rkets. As of September 30, 2025, we had $3.1 billion of backlog and awarded contracts, repre
• $545 m — f December 31, 2024, were approximately $545 million, $463 million, $350 million and $
• $463 m — 2024, were approximately $545 million, $463 million, $350 million and $260 million, r
• $350 million — proximately $545 million, $463 million, $350 million and $260 million, respectively, for the
• $260 m — million, $463 million, $350 million and $260 million, respectively, for the years ende
• $10 m — s that had contract prices of less than $10 million, after giving pro forma effect to
• $350.7 million — y, we paid subcontractors approximately $350.7 million and $234.8 million, respectively, in co
• $234.8 m — actors approximately $350.7 million and $234.8 million, respectively, in connection with
• $457.3 million — , 2024 and 2023, we spent approximately $457.3 million and $385.8 million, respectively, on eq
• $385.8 m — spent approximately $457.3 million and $385.8 million, respectively, on equipment for o
• $2,098.6 million — r ended December 31, 2024, we generated $2,098.6 million in revenue, $27.6 million in net loss a
• $27.6 million — generated $2,098.6 million in revenue, $27.6 million in net loss and $229.6 million in Adjus
• $229.6 million — revenue, $27.6 million in net loss and $229.6 million in Adjusted EBITDA representing a Net L

Filing Documents

• d77404ds1.htm (S-1) — 3339KB
• d77404dex11.htm (EX-1.1) — 201KB
• d77404dex51.htm (EX-5.1) — 15KB
• d77404dex211.htm (EX-21.1) — 10KB
• d77404dex232.htm (EX-23.2) — 1KB
• d77404dex233.htm (EX-23.3) — 1KB
• d77404dexfilingfees.htm (EX-FILING FEES) — 18KB
• g77404g00a03.jpg (GRAPHIC) — 38KB
• g77404g01a06.jpg (GRAPHIC) — 59KB
• g77404g32f08.jpg (GRAPHIC) — 3KB
• g77404g95h41.jpg (GRAPHIC) — 6KB
• g77404g99a01.jpg (GRAPHIC) — 106KB
• 0001193125-25-312729.txt ( ) — 3969KB
• d77404dexfilingfees_htm.xml (XML) — 5KB

Risk Factors

Risk Factors 18 Cautionary Note Regarding Forward-Looking Statements 57

Use of Proceeds

Use of Proceeds 59

Management's Discussion and Analysis of Financial Condition and Results of

Management's Discussion and Analysis of Financial Condition and Results of Operations 60 Industry Overview 100

Business

Business 102 Management 113 Compensation Discussion and Analysis 118 Principal and Selling Stockholders 136 Corporate Reorganization 139 Certain Relationships and Related Party Transactions 142 Dividend Policy 146

Description of Capital Stock

Description of Capital Stock 147 Material U.S. Federal Income Tax Considerations for Non-U.S. Holders 154 Underwriting (Conflicts of Interest) 159 Legal Matters 169 Experts 169 Where You Can Find More Information 170 Index to Financial Statements F-1 Neither we, nor the selling stockholders, nor the underwriters have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any amendment or supplement to this prospectus or in any free writing prospectus prepared by us or on our behalf. We, the selling stockholders and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any information other than the information in this prospectus and any free writing prospectus prepared by us or on our behalf. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since such dates. We and the selling stockholders are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. This prospectus contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control. "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" contain additional information regarding these risks. i Table of Contents COMMONLY USED DEFINED TERMS As used in this prospectus, unless the context indicates or otherwise requires, references to "LGN," "Legence," the "Company," "we," "us," "our" and like terms are to Legence Corp., a Delaware corporation, and its wholly owned subsidiaries. In addition, the terms listed below have the following meanings: "Aggregators" refers to, collectively, Legence Parent and Legence Par

View Full Filing

View this S-1 filing on SEC EDGAR